Lithoz GmbH, Vienna, Austria, reports that it has remotely installed a Lithoz CeraFab ceramic AM machine at the University of Wollongong (UOW), Australia. A partnership between Lithoz, UOW and Australia-based AM provider Objective3D enabled the remote installation of the machine, which will be used for a range of applications in the development of bioprinting hardware.
Purchased by the Australian National Fabrication Facility (ANFF) Materials Node, based at UOW, the machine is intended for use at the Translational Research Initiative for Cellular Engineering and Printing (TRICEP). TRICEP works with research institutions and industry to develop innovative technologies using what it calls ‘3D bioprinting’ – the use of AM for biomedical applications.
Dr Johannes Homa, Lithoz CEO, explained that the installation project highlighted the importance of agile working. “We are world and industry technology providers for ceramic 3D printing systems and materials, and have been working in research and industry for more than ten years. After the past year, it has become clear to us just how critical flexibility in the manufacturing world is, and we are very happy that this remote installation has been a success.”
The investment from ANFF will reportedly give TRICEP a highly flexible means of customising and producing devices to support material development research globally. TRICEP Associate Director A/Prof Stephen Beirne stated that the team was thrilled to have access to this exciting new technology.
“The CeraFab 3D printer provides us with access to new families of materials with properties and printing characteristics that greatly expand our service and research capabilities. The system will be immediately put to use in the development of next-generation biofabrication hardware and implantable structures.”